Literature DB >> 24012440

Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.

Luke R Donius1, Christopher M Orlando, Janis J Weis, John H Weis.   

Abstract

The enhancing effects of the complement system for humoral immunity have primarily focused upon the recognition of complement-bound foreign antigens by a co-receptor complex of the antigen-specific B cell receptor (BCR) and complement receptor 2 (Cr2). In vivo experiments using Cr2 gene deficient mice (which lack the expression of both the Cr1 and Cr2 proteins) do demonstrate depressed humoral responses to immunization but cannot be used to define specific contributions of the singular Cr1 or Cr2 proteins on B cell functions. To study the effect of a Cr2 deficiency in a Cr1 sufficient environment we created a mouse line in which the alternative splice site required for the expression of the Cr2 isoform was removed. This mouse line, Cr2KO, still expressed Cr1 on B cells but was deficient for the full length Cr2 protein. Surprisingly a new alternative splice within the Cr2 gene created a truncated product that encoded a novel protein termed iCr2 that was expressed on the surface of the cells. The Cr2KO mouse thus provides a new model system for the analysis of Cr1 and Cr2 functions in the immune response of the mouse.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Alternative splicing; B cell receptor; B cells; BCR; C3; Complement; Complement receptors; Cr1/CR1; Cr2/CR2; Follicular dendritic cells; IC; PCR; SCR; SS; TK; WT; complement component 3; complement receptor 1; complement receptor 2; follicular dendritic cell; gMFI; geometric mean fluorescent intensity; iCr2; incomplete Cr2; isotype control; polymerase chain reaction; s; short consensus repeat; signal sequence; thymidine kinase; wild type

Mesh:

Substances:

Year:  2013        PMID: 24012440      PMCID: PMC4133946          DOI: 10.1016/j.imbio.2013.08.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  30 in total

1.  Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons.

Authors:  Alan Tong; Jason Nguyen; Kristen W Lynch
Journal:  J Biol Chem       Date:  2005-09-19       Impact factor: 5.157

2.  HnRNP L represses exon splicing via a regulated exonic splicing silencer.

Authors:  Caryn R Rothrock; Amy E House; Kristen W Lynch
Journal:  EMBO J       Date:  2005-07-07       Impact factor: 11.598

3.  Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.

Authors:  Isabel Y Pappworth; Christine Hayes; Jason Dimmick; B Paul Morgan; V Michael Holers; Kevin J Marchbank
Journal:  Immunobiology       Date:  2011-06-25       Impact factor: 3.144

4.  Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL.

Authors:  Shalini Oberdoerffer; Luis Ferreira Moita; Daniel Neems; Rui P Freitas; Nir Hacohen; Anjana Rao
Journal:  Science       Date:  2008-07-10       Impact factor: 47.728

5.  Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner.

Authors:  Amanda C Jacobson; Janis J Weis; John H Weis
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

6.  CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.

Authors:  Karen M Haas; Jonathan C Poe; Thomas F Tedder
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

7.  Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.

Authors:  Luke R Donius; Jennifer M Handy; Janis J Weis; John H Weis
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

8.  Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2.

Authors:  Kirstin M Roundy; Janis J Weis; John H Weis
Journal:  Mol Immunol       Date:  2009-09-09       Impact factor: 4.407

9.  HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.

Authors:  Marco Preussner; Silke Schreiner; Lee-Hsueh Hung; Martina Porstner; Hans-Martin Jäck; Vladimir Benes; Gunnar Rätsch; Albrecht Bindereif
Journal:  Nucleic Acids Res       Date:  2012-03-08       Impact factor: 16.971

10.  CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies.

Authors:  S S Seregin; Y A Aldhamen; D M Appledorn; N J Schuldt; A J McBride; M Bujold; S S Godbehere; A Amalfitano
Journal:  Gene Ther       Date:  2009-06-25       Impact factor: 5.250

View more
  1 in total

1.  Relative Impact of Complement Receptors CD21/35 (Cr2/1) on Scrapie Pathogenesis in Mice.

Authors:  Sarah J Kane; Eric Swanson; Elizabeth O Gordon; Savannah Rocha; Heather R Bender; Luke R Donius; Adriano Aguzzi; Jonathan P Hannan; Mark D Zabel
Journal:  mSphere       Date:  2017-11-22       Impact factor: 4.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.